Chicago Health 2.0| How to Valuate an Early Stage Company Emphasis on Health Tech Startups
Have a wicked awesome idea for a health tech startup? Trying to figure out what it’s worth because you want to get it funded?
Or, maybe you have a profitable health tech company - and a bigger dog is sniffing around, considering an acquisition.
Perhaps you’re an angel investor and you’re wondering if you should invest in a pre-revenue health tech startup, but you don’t know much about valuating companies in the health tech space.
Come to this meetup and learn how valuation experts determine “price tags” for early stage companies and understand what factors affect them. Of course, we’re going to place a special emphasis on health tech. This session will be interactive, so come with questions.
Our expert panel:
Russ MacTough, Silicon Valley Bank Analytics. Russ is a director with SVB’s Corporate Advisory Services division where his group has performed thousands of complex valuations for venture backed companies. Learn more about Mr MacTough.
Jake Plummer, Allscripts and Hyde Park Angels. Jake is a VP of business development at Allscripts where he works closely with startups interested in adding value to the Allscripts ecosystem. He also evaluates health tech startups for possible angel or seed round investments as a member of Hyde Park Angels. Learn more about Mr Plummer.
Erica Chain, Rock Health and Silicon Valley Bank Analytics. Erica is a director at Rock Health, a non-profit foundation focused on the intersection of health and technology, with the first seed accelerator dedicated exclusively to interactive health startups. She also supports the venture eco-system at SVB Analytics as a consultant where she provides valuation services to private companies, with a sector focus on Health IT. Learn more about Ms Chain.
David Schonthal: an entrepreneur, manager and strategist with experience in industry, private equity and consulting. Mr Schonthal is an adjunct professor of entrepreneurship at Northwestern, a Catalyst at Ideo and a partner with Fusion Ventures. Learn more about Mr Schonthal.
Who should come? You! Especially if:
-You’re an entrepreneur considering innovation in the healthcare tech space vs non-healthcare verticals that may seem to have larger market share (like diabetes education vs travel comparison)
-You’re a health tech entrepreneur trying to figure out market segments within healthcare to help you decide whose problems you want to solve (like diabetics vs internists)
-You’re wondering if you should start raising your first round now, or if you should wait to hit certain milestones first (you have users, but revenue is still down the road)
-You’re raising money and you’ve been told your pre-revenue startup is worth $3 million USD pre-money by a prospective angel, but you have no %$^!ing clue how they figured that out (maybe they’re not taking the time to explain it to you vs they don’t know themselves, but are guessing based on other “similar” startups that are “health tech”)
-Your profitable company has an opportunity to be acquired and you want to make sure it’s a fair offer (duh!)
-You’re an angel investor but you’ve never invested in the health tech space and you’re wondering if you should start (yes!)
-You want to network with cool mavericks over Naked Pizza and craft beer.
6-7p: Pre-event networking with Naked Pizza, craft beer and non-alcoholic beverages
7-715p: Chicago Health Tech | Health 2.0 announcements + a word from our venue sponsor
715-815p: Panel discussion intermixed with audience Q & A
815-9p: Post-event networking
Learn More: Chicago Health 20 How to Valuate an Early Stage Company Emphasis on Health Tech Startups